Planet Labs Q2 FY27: Record Revenue, 58% Growth, and Fourth Consecutive Rule of 40—But Key Risks Persist

What happened

Planet Labs announced Q2 FY2027 results with revenue reaching $116.1 million, a 58% year-over-year increase that marks a sharp acceleration from Q1's 42% growth. The company reported its fourth consecutive quarter of meeting or exceeding the Rule of 40, indicating a strong balance between growth and profitability. This performance significantly outpaces the prior full-year guidance implying mid-30s percentage growth, suggesting robust demand execution. However, the press release does not disclose critical details such as gross margin, remaining performance obligations, cancelable backlog, or ATM usage. Consequently, while the top-line and Rule of 40 achievement are positive, they do not yet resolve the prior concerns around backlog quality, capital intensity, and dilution.

Implication

The Q2 revenue beat and Rule of 40 achievement directly counter the bear-case premise that growth would slow below 25% and margins would stagnate, as growth accelerated to 58% with improved profitability. This lowers the probability of the bear scenario from 30% to perhaps 20%, but the bull case still depends on evidence that RPO grew, the 12-month conversion rate improved above 35%, and the ATM was not used meaningfully. Without those confirmations, the stock's premium valuation and dilution overhang remain material risks. Investors should maintain a cautious stance, looking to the 10-Q filing for gross margin, RPO, and share count changes. If those metrics show improvement, the investment case would strengthen toward a buy; if not, the stock remains a hold with limited upside.

Thesis delta

The thesis previously required proof of faster backlog conversion, margin improvement, and minimal dilution before becoming constructive. The Q2 results provide strong evidence of accelerating growth and Rule of 40 achievement, which materially reduces the risk that revenue growth collapses or margins stay flat. However, the release lacks details on backlog quality, capital intensity, and ATM usage, so the thesis shifts from 'wait for evidence' to 'cautiously constructive pending confirmation of per-share value creation'.